Atlas Trials

Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome

Clinical trial NCT05697640 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05697640
Sponsor
Charite University, Berlin, Germany
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Post-COVID ME/CFS
Start date
2023-06-22
Primary completion
2026-04-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.